trial with title C3511001 Memento 1 - Meningococcal Vaccine Study

Memento-1 Meningococcal Vaccine Study


Am I Eligible?

About the Study

Meningococcal disease is caused by a germ. There are many different types of this germ. The Meningococcal germ can cause diseases such as infection of the brain lining (Meningitis). The likelihood of experiencing Meningococcal disease for any individual is low; however, adolescents and young adults have an increased risk of disease compared to older people. This study is being done with healthy adolescents and young adults to see if an investigational vaccine might help the body make antibodies and fight off different germs that cause meningococcal disease. 

There are three different vaccines that will be used during the study: two control vaccines and the investigational vaccine. The vaccine you receive in this study will be decided by chance, like flipping a coin. You will either receive the control vaccines or the investigational vaccine and a placebo. This study will look for any side effects and measure the number of antibodies produced in each person after receiving these vaccines. 

Medical Care

Participation in this study may last up to 1 year which will include at least 1 telephone call and 2 study site visits. Taking part in this study is voluntary and there is no penalty or change to your regular medical care if you decide not to participate.

How to Participate

If you choose to participate, you will undergo a series of screening assessments including:

  • Collection of demographic information

  • Physical examination

  • Provide blood sample (if required)

  • Provide urine sample (if female)

  • Review of health and current medications

  • Answer questions using an electronic diary. 

Taking part in this study is voluntary and there is no penalty or change to your regular medical care if you decide not to participate. We encourage you have conversations with family, caregivers, doctors and the study team about taking part in this study and whether it is right for you. 

Why Should I Participate?

The possible benefits of this study are that you may make antibodies that may protect you against the Meningococcal germ. Other people may benefit from the information that is learned during this study. Eligible participants will receive study related tests and procedures at no cost. Any research has some risks, but the clinical research team will discuss all study risks with you and answer any additional questions you may have.